| ASPsiRNA ID | Pairing of target region (top) and ASP-siRNA (bottom) | Efficacy (mut)(%) | Efficacy (wt) (%) | Diff | Gene | Disease | Mutation | RefSNP | Analysis | Pubmed ID |
|---|---|---|---|---|---|---|---|---|---|---|
| ASPsiRNA ID | Mutant allele/ASP-siRNA | Efficacy for mutant(%) |
Efficacy for wild (%) |
Relative Difference (%) | Gene | Disease | Mutation | RefSNP | Analysis | Pubmed ID |
| aspsirna0710 | UGUUGGAGACUUGCGCAAU ACAACCUCUGAACGCGUUA |
90 | 35 | 55 | SOD1 | Amyotrophic Lateral Sclerosis (ALS) | c.256G>C, p.Gly86Arg | rs12191243 | ||
| aspsirna0730 | UGUUGGAGACUUGCGCAAU ACAACCUCUGAACGCGUUA |
90 | 35 | 55 | SOD1 | Amyotrophic Lateral Sclerosis (ALS) | c.256G>C, p.Gly86Arg | rs12191243 | ||
| aspsirna0931 | GCAGCAGCAGCAGCGGGAC CGUCGUCGUCGUCGCCCUG |
80 | 80 | 0 | ATXN3 | Machado-Joseph Disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) | c.209_211CAG(8_36),(p.Gln298_Gln305=) | rs19392292 | ||
| aspsirna0953 | AAUCUUAAUGAUACAUUAG UUAGAAUUACUAUGUAAUC |
79 | 50 | 29 | KRT12 | Meesmann epithelial corneal dystrophy (MECD) | c.404G>C,p.Arg135Thr | rs57218384 | ||
| aspsirna2253 | UGUUGGAGACUUGCGCAAU ACAACCUCUGAACGCGUUA |
90 | 70 | 20 | SOD1 | Amyotrophic Lateral Sclerosis (ALS) | c.256G>C,p.Gly86Arg | rs12191243 | ||
| aspsirna2282 | UGUUGGAGACUUGCGCAAU ACAACCUCUGAACGCGUUA |
98 | 30 | 68 | SOD1 | Amyotrophic Lateral Sclerosis (ALS) | c.256G>C,p.Gly86Arg | rs12191243 | ||
| aspsirna2320 | UGUUGGAGACUUGCGCAAU ACAACCUCUGAACGCGUUA |
NA | NA | 9 | SOD1 | Amyotrophic Lateral Sclerosis (ALS) | c.256G>C,p.Gly86Arg | rs12191243 | ||
| aspsirna3166 | UCCCUCCUGCAGGCUGCGUGUU AGGGAGGACGUCCGACGCACAA |
55 | 25 | 30 | HTT | Huntington disease (HD) | rs362268 | rs362268 | ||
| aspsirna3174 | UCCCUCCUGCAGGCUGCGUGUU AGGGAGGACGUCCGACGCACAA |
60 | 25 | 35 | HTT | Huntington disease (HD) | rs362268 | rs362268 | ||
| aspsirna3514 | AAUCUUAAUGAUACAUUAG UUAGAAUUACUAUGUAAUC |
79 | 50 | 29 | KRT12 | Meesmann epithelial corneal dystrophy (MECD) | c.404G>C,p.Arg135Thr | rs57218384 | ||
| aspsirna3752 | AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUGCUCAA |
90 | 35 | 55 | PPIB/Cyclophilin B | PPIB-Related Osteogenesis Imperfecta (Type IX) | NA | NA |